\n
![](\"https:\/\/fortune.com\/img-assets\/wp-content\/uploads\/2024\/03\/GettyImages-2092481340-e1711816846476.jpg?w=2048\")
<\/p>\n [ad_1]
\n<\/p>\n
Eli Lilly & Co.<\/a>\u00a0said that some patients may have trouble getting its new weight loss drug Zepbound as complaints of backorders and delays mount across the US.<\/p>\n \u201cDue to the unprecedented demand for these medicines, some patients may experience difficulty when trying to fill their prescription at their pharmacy,\u201d a Lilly spokesperson said.<\/p>\n The\u00a0US Food and Drug Administration<\/a>\u00a0doesn\u2019t currently consider the obesity shot in shortage and Lilly said it \u201ccontinues to manufacture and ship all doses of Zepbound.\u201d<\/p>\n Rite Aid Corp.<\/a>\u00a0and Amazon<\/a> Pharmacy said that the drug was in short supply, and multiple pharmacists across the US told Bloomberg News that some or all of the doses of the drug were on backorder.<\/p>\n On the website of Amazon Pharmacy, which has a\u00a0partnership<\/a>\u00a0with Lilly, four doses of Zepbound are listed as unavailable. An Amazon spokesperson confirmed there is a \u201cnationwide shortage\u201d of some weight-loss medications, including Zepbound.<\/p>\n A Rite Aid<\/a> spokesperson told Bloomberg News the demand for the obesity shot has \u201ccreated some sporadic supply constraints.\u201d<\/p>\n Other large pharmacy chains, including\u00a0CVS Health Corp.<\/a>,\u00a0Walgreens Boots Alliance Inc.<\/a>, and\u00a0Walmart Inc.<\/a>\u00a0did not respond to requests for comment on their Zepbound supply.<\/p>\n Pharmacists say they\u2019re having difficulty ordering the drugs from major wholesalers. On Mar. 25, wholesaler\u00a0McKesson Corp.<\/a>\u2019s ordering system displayed to one pharmacist that all doses of Zepbound were on a supplier backorder, with the next release of drugs expected in early or mid-April, according to records reviewed by Bloomberg News. Full recovery of supply was \u201cTBD,\u201d the notice said.<\/p>\n Cardinal Health Inc.<\/a>, another distributor, was also reporting a manufacturer backorder for some doses of Zepbound and limiting shipments to pharmacies, said Richard Glotzer, owner and pharmacist at Drug Mart of Millwood in Westchester County. A CVS pharmacy technician in Ohio, who asked not to be identified, provided the same information.<\/p>\n McKesson<\/a> and Cardinal did not respond to requests for comment.<\/p>\n \u2014 With assistance from Jemima Denham<\/em><\/p>\n\nSubscribe to Well Adjusted, our newsletter full of simple strategies to work smarter and live better, from the Fortune Well team. Sign up<\/a> for free today.<\/div>\n<\/div>\n